2003
DOI: 10.1055/s-2003-38411
|View full text |Cite
|
Sign up to set email alerts
|

Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege

Abstract: EinleitungMit den "Richtlinien für die Durchführung von nasalen Provokationstests mit Allergenen bei Erkrankungen der oberen Luftwege" wurde 1990 vom "Arbeitskreis bronchiale und nasale Provokationstests" der Deutschen Gesellschaft für Allergologie und Klinische Immunologie ein Standard für die Diagnostik allergischer Erkrankungen in Deutschland geschaffen [1]. International liegt bisher keine vergleichbare klinische Handlungsgrundlage vor [2 -4]. Eine Aktualisierung der 1990 formulierten Richtlinien erfolgt, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
39
0
10

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(49 citation statements)
references
References 18 publications
0
39
0
10
Order By: Relevance
“…A positive NCT was required at inclusion in order to ensure that subjects were sensitive to the test allergen in the applied dose. The NCT was performed in accordance with previously validated protocols [31,32] modified to the position paper of the German Society for Allergology and Clinical Immunology [33] as described below. …”
Section: Methodsmentioning
confidence: 99%
“…A positive NCT was required at inclusion in order to ensure that subjects were sensitive to the test allergen in the applied dose. The NCT was performed in accordance with previously validated protocols [31,32] modified to the position paper of the German Society for Allergology and Clinical Immunology [33] as described below. …”
Section: Methodsmentioning
confidence: 99%
“…All participants had a history of birch pollen allergy with 1) moderate-to-severe seasonal allergic rhinoconjunctivitis and/or mild-to-moderate allergic asthma, 2) positive SPT reactivity to birch pollen extracts (ALK Prick SQ, ALK-Abelló, Hørsholm, Denmark), 3) serum IgE reactive with birch pollen extracts and rBet v 1 (Phadia ImmunoCAP System, Phadia, Uppsala, Sweden), and 4) a positive NPT to aqueous birch pollen extracts (ALK-depot SQ, ALKAbelló). NPT was performed with Rhinotest2000 (Allergopharma, Reinbek, Germany), according to the guidelines of the German Society for Allergy and Clinical Immunology (36). Exclusion criteria were polysensitization with perennial symptoms, clinically relevant allergies against additional pollen allergens, and chronic nonallergic asthma.…”
Section: Patientsmentioning
confidence: 99%
“…However, none of these methods is a generally accepted tool for interpreting CPT results [10]. On the contrary, the nasal provocation test is mentioned in the literature as the approved mucosal provocation tool [21] and is consistently defined in detail by international guidelines [6,11,22,23]. However, methods used to evaluate nasal provocation test results, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…However, methods used to evaluate nasal provocation test results, e.g. anterior rhinomanometry, lack in sufficient reproducibility [24,25,26] and depend greatly on the examiner's experience and on the patient's compliance [7,22]. …”
Section: Introductionmentioning
confidence: 99%